Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation

Abeona Therapeutics receives the Regenerative Medicine Advanced Therapy designation for its cell therapy for patients with recessive dystrophic epidermolysis bullosa.

Read More  >